Skip to content
The Policy VaultThe Policy Vault

Synarel (nafarelin acetate nasal solution – Pfizer)Cigna

Endometriosis

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Patient has tried ONE of the following, unless contraindicated (i, ii, or iii):
  • i. A contraceptive; OR
  • ii. An oral progesterone (e.g., norethindrone tablets); OR
  • iii. A depo-medroxyprogesterone injection.
  • Note: An exception to the requirement for a trial of the above therapies can be made if the patient has previously used a gonadotropin-releasing hormone (GnRH) agonist (e.g., Lupron Depot) or antagonist (e.g., Orilissa) for endometriosis.

Approval duration

6 months